Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.

FDA To Meet With Substance-Use Disorder Patients On Opioid Treatments, Effects

March 13, 2018
FDA will hold a meeting in April to garner patients' perspectives on the effects of and potential treatments for opioid use disorder (OUD), the agency announced Tuesday (March 13). The agency will focus on the symptoms and daily impacts of OUD that matter most to patients and patients' perspectives on current treatment approaches. “FDA is interested in learning patients’ perspectives on OUD, including the effects on their health and well-being that have the greatest negative effect on daily life, their...